BioVie Files for $50M Stock Offering Amid Cash Crunch
BIVI sits 39% above its 52-week low of $1.06.
Summary
BioVie filed an S-1 to raise up to $50 million in a best-efforts offering, following the $300M shelf registration filed in June. The company had less than eight months of cash as of May and a going concern warning, making this raise critical. The offering is highly dilutive given the $13.6M market cap, and best-efforts terms signal weak underwriter demand. The filing comes the same day as the S-1, adding urgency to the financing timeline.
At the time of this announcement, BIVI was trading at $1.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.6M. The 52-week trading range was $1.06 to $9.09. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.